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ABSTRACT: Enteric disease and immune challenge 
are processes that have detrimental effects on the 
growth performance of young swine. The current study 
tested the hypothesis that salmonella-induced enteric 
disease would perturb the endocrine growth axis in a 
serovar-dependent fashion. Specifically, we evaluated 
the effects of Salmonella enterica serovar Typhimurium 
(Typhimurium) and serovar Choleraesuis (Cholerae-
suis) on critical regulatory components of growth in 
young swine. Weaned pigs were housed 2 per pen with 
ad libitum access to feed and water in a 14-d experi-
ment. Pigs were then repeatedly fed 108 cfu of either 
Choleraesuis or Typhimurium in dough balls, with 
control pigs receiving dough without bacteria. Bacte-
ria were refed twice weekly. Rectal temperatures were 
monitored daily from d 0 to 7 and ADFI was measured 
through d 14. Pigs were weighed and samples of serum 
were obtained for circulating IGF-I on d 0, 7, and 14. 
At the conclusion of the study, samples of semitendi-
nosus muscle and liver were obtained and subsequently 
assayed for IGF-I, IGFBP-3, and IGFBP-5 mRNA. 
Rectal temperatures were elevated in pigs given Chol-
eraesuis from d 2 through 7 (P < 0.05) when compared 
with control pigs and pigs fed Typhimurium. Pigs re-
ceiving Choleraesuis had a substantially decreased feed 
intake on d 2, 3, 4, 7, 8, 9, and 10 (P < 0.01), with a 
trend for a reduction on d 5 (P = 0.08), and they expe-
rienced an approximately 25% reduction in BW com-
pared with control pigs and pigs given Typhimurium 
by the conclusion of the study. Pigs given Choleraesuis 
also experienced marked reductions in circulating IGF-
I on d 7 (P < 0.01 vs. control and Typhimurium), with 
reductions of lesser magnitude on d 14 (P = 0.07 vs. 
control and P < 0.05 vs. Typhimurium). Inoculation 
tended to affect liver IGFBP-3 mRNA (P = 0.08), for 
which expression tended to be elevated in pigs given 
Typhimurium and Choleraesuis. In contrast, IGFBP-3 
mRNA relative abundance was increased (P < 0.03) in 
pigs given Typhimurium compared with control pigs. 
Muscle IGF-I mRNA was reduced in pigs given Chol-
eraesuis compared with control pigs and pigs given 
Typhimurium (P < 0.05). Treatment tended to affect 
muscle IGFBP-3 mRNA (P = 0.10). Oral inoculation 
of growing pigs with Choleraesuis disrupted feed intake 
and BW gain, and this was accompanied by decreases 
in circulating IGF-I and reduced muscle expression of 
mRNA for IGF-I and IGFBP-3.
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INTRODUCTION
Enteric disease and immune challenge are processes 
that are generally associated with decreased growth in 
domestic livestock. In swine, oral infection by Salmo-
nella enterica serovar Typhimurium (hereafter referred 
to as Typhimurium) results in growth suppression and 
an array of associated physiological effects (Schwartz, 
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1999; Balaji et al., 2000; Jenkins et al., 2004). Infection 
by Salmonella enterica serovar Choleraesuis (hereafter 
referred to as Choleraesuis), another important swine 
pathogen, is more likely to cause septicemia in grow-
ing pigs (Schwartz, 1999), but little has been reported 
comparing these 2 serovars in terms of their effects on 
key regulatory elements of the endocrine growth axis. 
We have previously shown that infection by Typhimu-
rium results in unmistakable effects on systemic mark-
ers of the somatotropic growth axis, namely, serum 
IGF-I (Balaji et al., 2000; Burkey et al., 2004) and 
IGFBP-3, in pigs (Jenkins et al., 2004). In the current 
study, our objective was to directly compare the effects 
of oral inoculation with Typhimurium and Choleraesuis 
on weaned pigs because each serovar produces differing 
effects on swine, with Typhimurium producing main-
ly self-limiting enteritis and Choleraesuis, a so-called 
swine host-adapted pathogen, being more likely to re-
sult in a more serious and occasionally fatal septicemia 
(Schwartz, 1999). Therefore, we hypothesized that the 
effects of these 2 serovars in pigs on known promoters 
of growth in pigs would differ as well.
MATERIALS AND METHODS
The experimental protocol used in this study was 
approved by the Kansas State University Institutional 
Animal Care and Use Committee.
Experimental Design
The current study reports data from additional tissue 
collections and measurements made from a previously 
published study (Fraser et al., 2007). Essential details of 
that study and others specific to the current report are 
included here for clarity. Forty-eight weaned pigs were 
blocked by sex and BW and then randomly assigned to 
1 of 3 treatments in a 14-d study. Each treatment had 8 
replicates (pens) containing 1 barrow and 1 gilt in each 
pen. In total, 16 pigs served as negative controls, 16 
pigs were repeatedly fed 108 cfu of Typhimurium, and 
16 pigs were repeatedly fed 108 cfu of Choleraesuis. All 
pigs received treatments in the form of hand-fed dough 
balls. On d 0, pigs were fed 108 cfu of Choleraesuis 
or Typhimurium in dough balls, with control pigs re-
ceiving dough balls without bacteria. Dough balls were 
then refed on d 3, 7, and 10, resulting in animals receiv-
ing treatment twice weekly through the course of the 
14-d study. Details of bacterial culture were described 
previously (Fraser et al., 2007). All pigs were confirmed 
to be negative for salmonella organisms by fecal culture 
before inclusion in the study.
Pig BW were recorded on d 0, 7, and 14, and feeders 
were weighed daily to estimate ADFI. Rectal tempera-
tures were obtained daily from 1 pig/pen (same animal 
each day) from d 0 of the study until 7 d postchallenge. 
Serum samples were also taken from 1 pig/pen (same 
animal as for rectal temperature) on d 0, 7, and 14 to 
assay for circulating IGF-I. All pigs were killed at the 
conclusion of the study, and tissue samples of semi-
tendinosus muscle and liver were taken for analysis of 
IGF-I, IGFBP-3, and IGFBP-5 mRNA expression. All 
tissue samples were rapidly frozen in liquid nitrogen 
after collection.
Serum Analysis
Serum was collected from a single pig/pen for analy-
sis of circulating IGF-I on d 0, 7, and 14. Serum was 
subsequently analyzed for circulating IGF-I concentra-
tions via an immunoradiometric assay described previ-
ously for use in swine (Balaji et al., 2000).
RNA Extraction and Reverse Transcription
Samples of muscle and liver tissue were subjected to 
total RNA extraction using TRI-Reagent (Sigma Corpo-
ration, St. Louis, MO) according to the protocol of the 
manufacturer. After RNA isolation, removal of contam-
inating genomic DNA was performed with a DNA-free 
kit (Ambion Inc., Austin TX). Further quantification 
of isolated total RNA was done by spectrophotometry, 
using an optical density of 260 nm. Quality of total 
RNA was assessed by visualization of the 28S and 18S 
rRNA after electrophoresis of samples at 100 V for 1 h 
through 1% agarose-formaldehyde gels with ethidium 
bromide staining. Reverse transcription was performed 
using Taqman reverse transcription reagents (Applied 
Biosystems, Foster City, CA) and was conducted in a 
50-μL final volume consisting of 25 mM magnesium 
chloride, 500 μM deoxynucleotide 5′-triphosphate, 2.5 
μM random hexamers, 0.4 U/μL of ribonuclease inhibi-
tor, and 50 U/μL of MultiScribe reverse transcriptase 
and Taqman reverse transcription buffer. The reverse 
transcription mixture was then incubated at 25°C for 
10 min, heated to 37°C for 60 min, and inactivated at 
95°C for 5 min. The resultant cDNA was then stored at 
−80°C until later use.
Real-Time PCR Analysis  
for Gene Expression
Real-time quantitative PCR was used to measure the 
relative abundance of mRNA for IGF-I, IGFBP-3, IG-
FBP-5, and 18S rRNA in skeletal muscle and hepatic 
tissues. The PCR reactions were carried out in 96-well 
plates using 900 nM of the appropriate forward and 
reverse primers along with 200 nM of the appropri-
ate Taqman detection probe, PCR Mastermix (Applied 
Biosystems), and 3.5 μL of the cDNA sample. The por-
cine specific primers and detection probes were synthe-
sized from published GenBank sequences using Primer 
Express software (Applied Biosystems) and were identi-
cal to those published previously (Brown et al., 2007).
Statistical Analyses
Data were analyzed using the MIXED procedure 
(SAS Inst. Inc., Cary, NC). Data for rectal tempera-
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ture, ADFI, BW, and serum IGF-I concentrations were 
analyzed as a randomized block design with repeated 
measures over time for each experimental unit (pens). 
Terms for the fixed effects of disease challenge, time, 
and their interactions were included, with block and 
pen being considered random effects. Relative abun-
dance of mRNA for genes of interest was calculated rel-
ative to 18S rRNA. Muscle and liver mRNA data were 
also analyzed via the MIXED procedure, but without 
terms for repeated measures and without time state-
ments included in the model. Pen was also considered 
the experimental unit for all mRNA data. All means 
expressed are least squares means.
RESULTS
Rectal temperatures were monitored daily from d 0 
through 7 after the first bacterial feeding. There were 
no differences in rectal temperatures between control 
and Typhimurium-fed pigs in the first 7 d after chal-
lenge (Figure 1). In contrast, pigs given Choleraesuis 
experienced increased rectal temperatures beginning on 
d 2 and continuing through the end of the monitoring 
period at d 7 when compared with both control and 
Typhimurium-fed pigs (P < 0.05).
Average daily feed intake was measured by weigh-
ing feeders for each pen of pigs within each treatment 
daily (Figure 2), and was monitored from d 0 through 
the completion of the study on d 14. In general, ADFI 
between control pigs and pigs given Typhimurium did 
not differ (P > 0.10), with the exception that ADFI 
tended to be less in Typhimurium on d 14 (P = 0.08). 
Conversely, Choleraesuis-challenged pigs had reduced 
ADFI on d 2, 3, 4, 7, 8, 9, and 10 (P < 0.01) and a 
tendency for reduced ADFI on d 5 (P = 0.08).
Body weights were obtained by weighing pigs on d 0, 
7, and 14 (Figure 3). Pigs were initially blocked by BW 
so, as expected, there were no differences in BW across 
treatments at d 0. However, pigs fed Choleraesuis had 
reduced BW on d 7 and 14 compared with control pigs 
and pigs given Typhimurium (P < 0.01).
Circulating IGF-I concentrations (Figure 4) were not 
different on d 0 between the control, Typhimurium, 
and Choleraesuis treatments. Moreover, serum IGF-
I in control pigs and pigs receiving the Typhimurium 
treatment remained similar through d 14. In contrast, 
pigs challenged with Choleraesuis had less circulating 
IGF-I on d 7 when compared with both control and 
Typhimurium-fed pigs (P < 0.01). In addition, Choler-
aesuis-fed pigs had reductions in serum IGF-I on d 14 
when compared with control pigs (P < 0.07) and pigs 
given Typhimurium (P < 0.05).
Relative abundance of mRNA for IGF-I, IGFBP-3, 
and IGFBP-5 (Figure 5) in liver tissue of pigs across all 
treatments was variable. Only 1 treatment difference 
was observed for hepatic tissue, with Typhimurium-fed 
pigs having a greater relative abundance of IGFBP-3 
mRNA compared with control pigs (P < 0.03). How-
ever, in the statistical model for hepatic IGFBP-3, it 
should be noted that the main effect of treatment only 
approached significance, at P = 0.08.
For muscle tissue (Figure 6), pigs challenged with 
Choleraesuis had reductions in IGF-I mRNA expression 
Figure 1. Rectal temperatures of pigs orally administered 108 cfu 
of Salmonella enterica serovar Typhimurium or Choleraesuis from d 0 
through 7 after challenge. Bacteria were fed on d 0, 3, 7, and 10. Con-
trol pigs received dough balls without bacteria. Asterisks indicate days 
when rectal temperatures in pigs given Choleraesuis were increased 
relative to control pigs and pigs given Typhimurium (P < 0.05). Bars 
associated with symbols represent the SEM.
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when compared with control (P < 0.04) and Typhimu-
rium-fed pigs (P < 0.002). In addition, Choleraesuis-fed 
pigs had reductions in IGFBP-3 mRNA expression in 
skeletal muscle when compared with control pigs (P < 
0.03), although the overall treatment effect in the sta-
tistical model only tended to be significant (P = 0.10).
DISCUSSION
Our laboratory has published findings from weaned 
pigs challenged with the same isolate of Typhimurium 
as used in the current study and we have noted its ef-
fects on several variables in pigs, including known sys-
temic mediators of growth and development (Balaji et 
al., 2000; Turner et al., 2002a,b; Jenkins et al., 2004). 
However, the single oral dosages used for bacterial chal-
lenge were greater in the previous experiments, ranging 
from 109 to 1010 cfu. In the current experiment, we mod-
ified the approach to include an isolate of Choleraesuis 
to compare with Typhimurium and we used a smaller 
dose of bacteria (108 cfu) but administered it repeat-
edly. This was done to model more closely the fecal-oral 
transmission of salmonella organisms often found in in-
tense swine management and production conditions. 
We reasoned that, given the institutional animal com-
pliance requirement to wash pens daily, a bacterial load 
comparable with production conditions might not ac-
cumulate unless pigs were purposefully given repeated 
small-dose exposure. In addition, we included repeated 
exposure to Typhimurium and Choleraesuis in an effort 
to create a model of disease-associated growth suppres-
sion.
In the current study, we tracked rectal temperature, 
ADFI, and BW as ancillary measures to document the 
course of treatment-induced enteric disease. Growth 
performance data for this experiment were reported pre-
viously (Fraser et al., 2007). Clearly, all these measures 
were affected adversely by repeated oral exposure of 
pigs to Choleraesuis. In contrast, none of these measures 
was affected by repeated exposure of pigs to Typhimu-
rium (current report; Fraser et al., 2007). Although we 
expected Typhimurium to disrupt ADFI, and thereby 
potentially reduce BW, the oral dose of Typhimurium 
used in the study was small relative to oral doses re-
ported to provoke enteric disease (Schwartz, 1999) and 
relative to those we have used previously (Balaji et al., 
2000; Turner et al., 2002a,b). Moreover, although we 
did not formally track fecal shedding of Typhimurium, 
we are certain live Typhimurium organisms were being 
consumed and shed in the feces because organisms for 
refeeding were successfully cultured from fecal collec-
tions pooled from pens of pigs inoculated orally with 
Typhimurium.
We evaluated circulating IGF-I because it is widely 
accepted that IGF-I can be evaluated as a marker of 
performance and growth (Florini et al., 1996; Oksbjerg 
et al., 2004; Sheffield-Moore and Urban, 2004). Further-
more, it is established that bacterial infection (Balaji 
et al., 2000) and other noninfectious models of sepsis 
(Orellana et al., 2002; Thissen et al., 2005) can lead to 
decreases in IGF-I in circulation, with these decreases 
often paralleling reductions in feed intake. In the cur-
rent study, pigs challenged with Typhimurium consis-
tently had circulating IGF-I concentrations very similar 
to those of control pigs. Although this contrasts with 
Figure 2. Average daily feed intake of control pigs and pigs orally 
administered 108 cfu of Salmonella enterica serovar Typhimurium or 
Choleraesuis. Bacteria were fed on d 0, 3, 7, and 10. Control pigs re-
ceived dough balls without bacteria. Pigs fed Choleraesuis experienced 
reductions in intake on d 2, 3, 4, 7, 8, 9, and 10 (P < 0.01), with a 
trend for a reduction on d 5 (P = 0.08) when compared with control 
pigs. Trt = treatment. Error bars represent the SEM.
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previous findings from our group for pigs challenged 
with Typhimurium (Balaji et al., 2000; Turner et al., 
2002a,b; Jenkins et al., 2004), the finding is consistent 
with the lack of effect of Typhimurium on ADFI in the 
current study, which we think is likely a consequence of 
the smaller dose of Typhimurium used here.
In contrast to pigs receiving Typhimurium, pigs re-
ceiving Choleraesuis at this same dosage experienced 
marked reductions in serum IGF-I. This observation 
is consistent with other pathophysiological effects of 
Choleraesuis observed in the current study, most no-
tably treatment-induced reductions in ADFI. However, 
of potentially greater significance is our finding that, 
in addition to circulating IGF-I, pigs challenged with 
Choleraesuis experienced reduced steady-state abun-
dance of muscle mRNA for both IGF-I and IGFBP-3. 
Although decreases in IGF-I mRNA in skeletal muscle 
have been documented after administration of lipopoly-
saccharide (Fan et al., 1994; Fernández-Celemín et al., 
2002), our findings in the current study indicate what 
we believe to be the first chronic disease model that has 
been documented to disrupt IGF-I and IGFBP-3 locally 
in skeletal muscle. Our working hypothesis is that these 
effects are most probably related to the decreased feed 
intakes of pigs challenged with Choleraesuis because 
there is a strong body of evidence that nutrient intake 
plays a major role in the regulation and expression of 
critical mediators of growth (Breier, 1999; Ling and 
Bistrian, 2005; Thissen et al., 2005). Although the ef-
fect of Choleraesuis in reducing skeletal muscle mRNA 
for IGFBP-3 is consistent with reduced muscle IGF-I 
mRNA, we caution that the overall treatment effect for 
IGFBP-3 mRNA only approached significance.
Emerging dogma linking disease to mechanisms of 
reduced growth potential suggests that changes in feed 
intake, often found with animals experiencing a dis-
Figure 3. Body weights of control pigs and pigs orally adminis-
tered 108 cfu of Salmonella enterica serovar Typhimurium or Choler-
aesuis. Bacteria were fed on d 0, 3, 7, and 10. Control pigs received 
dough balls without bacteria. Pigs receiving Choleraesuis weighed less 
on d 7 and 14 compared with control pigs and pigs fed Typhimurium 
(a vs. b, P < 0.01). Error bars represent the SEM.
Figure 4. Serum IGF-I concentrations in control pigs and pigs 
orally administered 108 cfu of Salmonella enterica serovar Typhimu-
rium or Choleraesuis. Bacteria were fed on d 0, 3, 7, and 10. Control 
pigs received dough balls without bacteria. Bars without common let-
ters within a day differ (a vs. b, P < 0.01; c vs. e, P = 0.07; d vs. e, P 
< 0.05). Error bars represent the SEM.
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Figure 5. Expression of IGF-I, IGFBP-3, and IGFBP-5 mRNA 
in liver tissue of control pigs and pigs orally administered 108 cfu of 
Salmonella enterica serovar Typhimurium or Choleraesuis. Bacteria 
were fed on d 0, 3, 7, and 10. Control pigs received dough balls with-
out bacteria. Pigs were killed on d 14. For liver IGFBP-3 mRNA, bars 
without common letters differ (a vs. b, P < 0.03).  Error bars represent 
the SEM.
Figure 6. Expression of IGF-I, IGFBP-3, and IGFBP-5 in semiten-
dinosus muscle tissue of control pigs and pigs orally administered 108 
cfu of Salmonella enterica serovar Typhimurium or Choleraesuis. Bac-
teria were fed on d 0, 3, 7, and 10. Control pigs received dough balls 
without bacteria. Pigs were killed on d 14. For muscle IGF-I mRNA 
and IGFBP-3 mRNA, bars without common letters differ (a vs. b, P 
< 0.05). Error bars represent the SEM.
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ease challenge, are manifested by elevated peripheral 
proinflammatory cytokines (Kelley et al., 1993; John-
son, 1997), with tumor necrosis factor-α, IL-1, and IL-6 
being predominantly implicated in altering metabolism 
and growth (Spurlock, 1997). It is of interest to note 
that in the companion study conducted with pen mates 
of pigs from the current study, Choleraesuis challenge 
was not associated with increased circulating tumor ne-
crosis factor-α or IL-1β (Fraser et al., 2007). However, 
it is important to note that local production of inflam-
matory cytokines not measured in the current study 
may be of greater importance and more reflective of 
local regulation of skeletal muscle growth than systemic 
cytokines (reviewed in Gabler and Spurlock, 2008).
Although pigs challenged with repeated oral doses of 
Choleraesuis experienced reductions in IGF-I and IG-
FBP-3 mRNA in skeletal muscle, these treatment ef-
fects were not found in hepatic tissue. In fact, the only 
effect in hepatic tissues was an elevation in IGFBP-3 
mRNA in pigs fed Typhimurium compared with con-
trol pigs, with pigs fed Choleraesuis being intermediate 
between the other treatments. The physiological sig-
nificance of this isolated effect is not readily apparent, 
especially in the context of no other treatment effects of 
repeated Typhimurium feeding at the dose used in the 
current study. Moreover, the overall treatment effect 
in the statistical model, like that of muscle IGFBP-3 
mRNA, only approached significance. Hence, this trend 
should be considered with caution.
In conclusion, data from the current study document, 
for the first time in pigs, both systemic and local per-
turbation of the IGF system in skeletal muscle associ-
ated with Choleraesuis-induced disease. Although we 
expected a priori effects of Typhimurium, at least on 
systemic IGF-I, the lack of effect of Typhimurium at 
the dose used in the current study supports our hy-
pothesis of serovar-specific effects on growth in pigs. 
Perhaps these effects reflect the more systemic nature 
of Choleraesuis in contrast to the more enteric nature 
of Typhimurium. Whether local effects on regulation 
of the muscle IGF system are common to other enteric 
diseases of swine and whether greater doses of Typh-
imurium would result in similar kinds of changes are 
intriguing questions for future research.
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